| Tyler Masson, PHARMD | |
|
101 Boulder Point Dr Rm 1009, Plymouth, NH 03264-3170 | |
| (603) 346-4481 | |
| Not Available |
| Full Name | Tyler Masson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 101 Boulder Point Dr Rm 1009, Plymouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326472663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3924 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tyler Masson, PHARMD 101 Boulder Point Dr Rm 1009, Plymouth, NH 03264-3170 Ph: () - | Tyler Masson, PHARMD 101 Boulder Point Dr Rm 1009, Plymouth, NH 03264-3170 Ph: (603) 346-4481 |
News Archive
The COVID-19 pandemic is the most severe global health crisis of the 21st century. While media reports and policy directives tend to focus on the health and economic aspects of the pandemic, new research suggests that the pandemic is also destabilizing the fundamental relationship between citizens and the state.
Text4baby, a program of the National Healthy Mothers, Healthy Babies Coalition, has been honored with a U.S. Department of Health and Human Services HHSinnovates award, presented by HHS Secretary Kathleen Sebelius at a ceremony in Washington, DC. This week, Representatives from HMHB, Voxiva, Health Resources and Services Administration, Centers for Disease Control and Prevention and the HHS Office on Women's Health accepted the award on behalf of the text4baby team.
Injuries to the spinal cord can cause paralysis and other permanent disabilities because severed nerve fibers do not regrow. Now, scientists of the German Center for Neurodegenerative Diseases have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections.
Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection. The findings of a Phase 1b clinical trial and an in vitro study of SD-101's mechanism of action show that the second-generation TLR9 agonist is well tolerated and safe and induces both IFN-lambda and IFN-alpha at concentrations producing antiviral activity. The data will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria in April 2010.
Findings published in the journal Behavioral Ecology reveal that skin with yellow and red pigments is perceived as more attractive in Caucasian males, but this skin coloring does not necessarily signal actual good health.
› Verified 3 days ago
Nicole Uhlman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Main St, Plymouth, NH 03264 Phone: 603-536-4377 | |
Christopher Ross, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Main St, Plymouth, NH 03264 Phone: 603-536-4377 | |
Nolan Manning, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Hatch Shopping Plaza Route 25, Plymouth, NH 03264 Phone: 603-536-3233 | |
Mrs. Karen Marie Torrey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Main St, Plymouth, NH 03264 Phone: 603-536-4377 | |
Laurie Logue, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 683 Tenney Mountain Hwy, Plymouth, NH 03264 Phone: 603-536-5352 | |
Medora Decoteau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Main St, Plymouth, NH 03264 Phone: 603-536-4377 Fax: 603-536-1146 |